Business description: PCAS
- synthesized pharmaceutical products (63.5%);
- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).
At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.
France accounts for 76% of net sales.
Number of employees: 1,178
Sales by Activity: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
Pharmaceutical Synthesis | 128M | 135M | 120M | 144M |
Fine Speciality Chemicals | 73.25M | 58.92M | 67.41M | 82.72M |
Geographical breakdown of sales: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
France | 163M | 155M | 143M | 172M |
Other Areas | 38.01M | 38.92M | 44.36M | 54.3M |
Executive Committee: PCAS
| Manager | Title | Age | Since |
|---|---|---|---|
Gildas Barreyre
CEO | Chief Executive Officer | 43 | 2025-05-02 |
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 1999-02-28 |
Composition of the Board of Directors: PCAS
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 2014-02-28 | |
Janine Cossy
BRD | Director/Board Member | - | - |
Company details: PCAS
PCAS SA
21, Chemin de la Sauvegarde
69134, Écully
+33 1 69 09 77 85
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | +1.79% | +41.83% | +158.62% | 1,035B | |
| +0.45% | +2.81% | +52.75% | +49.66% | 574B | |
| -0.04% | -0.98% | +16.93% | +63.36% | 397B | |
| +0.66% | +0.77% | +21.19% | +15.95% | 324B | |
| -0.60% | -2.89% | +22.01% | +13.76% | 281B | |
| +0.77% | +3.70% | +24.75% | +34.68% | 278B | |
| +1.46% | +5.50% | -44.73% | -47.54% | 193B | |
| +0.66% | +1.27% | +19.08% | +62.87% | 191B | |
| -0.60% | -3.36% | +11.40% | +60.31% | 156B | |
| Average | +0.15% | +1.68% | +18.36% | +45.74% | 381.1B | |
| Weighted average by Cap. | -0.08% | +2.39% | +28.29% | +72.54% |
